Selected Talks

American Society of Nephrology (ASN) Renal Week
St. Louis, MO. October, 2004
Post-tests not yet ready


 
Inherited Defects in Urinary Concentration
Daniel Bichet, MD


 
Calciphylaxis
Anthony Bleyer, MD
CME accreditation good until May 1, 2006


1.5
Non-Standard Therapy in Membranous Nephropathy
Giuseppe Remuzzi, MD
Acute Renal Failure and Chronic Renal Failure after Orthotopic Liver Transplantation
Gabriel Contreras, MD, MPH


2.0
Sexual Dysfunction in Patients with Chronic Kidney Disease
Biff L. Palmer, MD
Sleep Apnea: ESRD vs. the General Population
Robert L. Benz, MD
Vexing Problems in the dialysis unit: Heparin-induced Thrombocytopenia
Eugene C. Kovalik, MD


1.5
The Metabolic Syndrome and Kidney Disease: An Important Complication of Systemic Vascular Disease
Katherine R. Tuttle, MD
Coronary Artery Catheterization in Chronic Kidney Disease: Indications and Management with Stent or Bypass
Connie L. Manske, MD


2.0
Indications for Immunosuppression in Membranous Nephropathy
Daniel C. Cattran, MD
ANCA-associated RPGN: Role of Plasmapheresis
Charles D. Pusey, MD
Therapy of ANCA-Associated Vasculitis and the EUVAS Trials
David Jayne, MD


 
Management of Fistula Failures
Gerald A. Beathard, MD


1.5
Primary Prevention of Dye-Induced Acute Renal Failure
Samuel N. Heyman, MD
When and How to Use the Selective Aldosterone Receptor Antagonists to Optimize Cardiorenal Event Reduction
George Bakris, MD


1.0
New Insights in the Pathogenesis of Uric Acid Nephrolithiasis
Khashayar Sakhaee, MD


1.5
Official Symposium: Cardiovascular Disease in CKD: Strategies for Reducing Risk
George Aronoff, MD; Phyllis August, MD; Jonathan Himmelfarb, MD; David Van Wyck, MD; (ASN Renal Week Official Symposium, St. Louis, MO, 2004)


1.5
Official Symposium: Infections and Renal Complications of Immunosuppression: An Update
David Roth, MD; Connie L. Davis, MD; Daniel C. Brennan, MD. (ASN Renal Week Official Symposium, St. Louis, MO, 2004)


3.5
Chronic allograft nephropathy and recurrent disease
Brian J. Nankivell, MD
Donor - Recipient Evaluation
Connie Davis, MD
B Cell and the Humoral Alloimmune Response
Mark D. Denton, MD, PhD
Immunosuppression: Induction and Maintenance
Flavio Vincenti, MD


2.0
Official Symposium: Emerging Data on Iron Management: Clinical Implications
Daniel Coyne, MD; Bradley A. Warady, MD, Kamyar Kalantar-Zadeh, MD, PhD, MPH; Allen R. Nissenson, MD. (Moderator: Allen R. Nissenson, MD) ASN Renal Week Official Symposium, St. Louis, MO, 2004)


2.0
Official Symposium: CKD and CHF: the Silent Threat.
Donald Silverberg, MD, Ajay K. Singh, MB, MRCP, and Anju Nohria, MD; (Moderator: Robert Provenzano, MD.) ASN Renal Week Official Symposium, St. Louis, MO, 2004)


1.5
Official Symposium: Meeting the K/DOQI Mineral and Bone Guidelines in CKD (Stages 3 and 4): The Essential Role of Vitamin D
(Glenville Jones, PhD, Jill S. Lindberg, MD; (Moderator: Tilman Drueke, MD.) ASN Renal Week Official Symposium, St. Louis, MO, 2004)


1.0
Fetal Kidney Cells, Identification And Roles As Future Therapeutic Agents
Stanton Gerson, MD


2.0
Official Symposium: Patients with CKD: Preventing the Complications of Mineral and Metal Accumulation in a Closed System
Paolo Raggi, MD, John Rumberger, PhD, MD, and Sharon M. Moe, MD. Moderators: Sharon M. Moe, MD and Isidro B. Salusky, MD.


1.0
Renin-Angiotensin System Actions and Interactions in CKD
Sharon Anderson, MD


1.5
Official Symposium: AA Amyloidosis: Diagnosis and Management.
Maria Picken, MD, PhD and Joseph Mikhael, MD, MEd


1.0
Advances in Treatment of FSGS
Frederick. J. Kaskel, MD


1.0
Official Symposium: Evolving Strategies for Renoprotection: From ACEI to Enzyme Replacement Therapy (ERT). Fabry's Disease. The Nephrologist's Perspective.
David Warnock, MD and Barry Brenner, MD (discussant)


1.0
Basic Science Conference. Aldosterone: Its Receptor, Target Genes, and Actions
David Pearce, MD


1.0
Postgraduate Education Course: Biology of Stent Stenosis and Potential Therapies
Alexander Clowes, MD


Please look also at related talks from
2003 ASN Renal Week Talks
2002 ASN Renal Week Talks
2001 ASN Renal Week Talks
2000 ASN Renal Week Talks
1999 ASN Renal Week Talks
1998 ASN Renal Week Talks

  
To disseminate new knowledge regarding scientific and clinical discoveries in the field of nephrology
To expand the scope of research in nephrology by providing exciting advances in related disciplines
To discuss contemporary standards and new approaches to clinical care in order to ensure the highest quality of care for patients with renal disease and related disorders
To review, update, and put into perspective the recent advances in many key areas of general nephrology, dialysis, transplantation, and hypertension

See Individual Lecture Pages

Each talk, depending on its length, is accredited for up to 1.0 CME Category 1 credits by the American Society of Nephrology. Sometimes talks are organized into groups of two or more and paired with a single CME post-test, which must be completed along with an evaluation form for 1.0 or more CME Category 1 credits.
Date of Web Release: See individual talks
CME Credit Eligible Through: See individual talks
CME Category 1 Credits/Completion Time: See individual talks
Target Audiences: Nephrology Board and Recertification candidates practicing nephrologists and internists.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Nephrology designates this educational activity for category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.
SPONSORSHIP / SUPPORT :
All lectures selected were from Renal Week 2004, and all were put together under supervision of the ASN Scientific Program Committee. Web posting of lectures in the free zone was supported by grants to the ASN from pharmaceutical companies. See each symposium page for details of industry sponsorship and support.
FACULTY DISCLOSURE STATEMENTS :
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.